Consolidated Statements of Cash Flows (Unaudited) - USD ($)	3 Months Ended
	Mar. 31, 2026	Mar. 31, 2025
Cash flows from operating activities:
Net loss	$ (331,433)	$ (1,347,440)
Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation and amortization	20,850	20,349
Net losses realized on the sale of securities and net credit losses recognized in operations	107,043	909,121
Unrealized losses on equity securities	45,610	21,790
Change in fair value of embedded derivative	(40,846)	118,762
(Accretion) amortization of investment securities, net	(24,621)	(102,099)
Deferred acquisition costs capitalized	(208,127)	(355,696)
Deferred acquisition costs amortized	214,933	167,924
Value of business acquired amortized	23,105	23,105
Interest credited on deposit type contracts	536,786	519,097
(Increase) decrease in operating assets:
Investment income due and accrued	(138,739)	(64,258)
Reinsurance related assets	56,674	(419,501)
Deferred tax assets, net of valuation allowance	(138,118)	(333,255)
Other assets	(103,519)	6,561
Increase (decrease) in operating liabilities:
Policyholder benefit reserves	1,468,963	1,744,897
Dividend accumulation	815	(1,240)
Advance premiums	(35,810)	(11,090)
Other liabilities	889,117	477,961
Accounts payable and accrued expenses	(208,124)	878,170
Net cash provided by operating activities	2,134,559	2,253,158
Cash flows from investing activities:
Purchase of fixed income investments	(4,845,563)	(1,863,263)
Purchase of equity investments	(5,332,667)	(461,430)
Purchase of mortgage investments	(2,941,631)	(132,785)
Purchase of other invested assets	(33,551)	0
Proceeds from fixed income sales and repayments	1,894,900	3,148,409
Proceeds from equity sales	529,195	3,000
Proceeds from mortgage repayments	388,895	561,216
Proceeds from other invested assets	15	0
Increase in policy loans	(767)	(768)
Purchase of property, equipment and software	(27,441)	0
Net cash (used in) provided by investing activities	(10,368,615)	1,254,379
Cash flows from financing activities:
Receipts on deposit-type contracts	1,867,110	1,311,824
Withdrawals on deposit-type contracts	(2,165,861)	(5,011,589)
Restricted stock awards	9,886	9,886
Net cash used in financing activities	(288,865)	(3,689,879)
Net increase (decrease) in cash and cash equivalents	(8,522,921)	(182,342)
Cash and cash equivalents:
Beginning	18,036,904	6,903,783
Ending	$ 9,513,983	$ 6,721,441